Skip to main content
2025 CRT Conference Main banner
Back

CRT 2025

Coronary

ACS and AMI Management

Antithrombotic Benefits of Glucose Lowering Agents | Effects Beyond Glycemic Control

Sunday, March 9, 2025
2:54 PM – 3:02 PM ET

    Speaker(s)

  • Paul A. Gurbel, MD, FSCAI

    Director
    Sinai Center for Thrombosis Research and Drug Development
    Baltimore, Maryland, United States

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Paul A. Gurbel, MD, FSCAI: No financial relationships to disclose